Volker Sandig, Ph.D.

Chief Scientific Officer at ProBioGen AG

Speaker

Volker has been part of ProBioGen since 2000. In that year, he initiated the company's cell line development program, which resulted in the unique CHO.RiGHT^® platform for protein production. He is the co-inventor of our key technologies, including the AGE1 designer cell lines, GlymaxX^® and DirectedLuck^®. His current work aims to modernize viral vector manufacturing and establish new platforms for RNA delivery. This includes customized design of suspension cell lines for viral vaccines as well as packaging and producer cell lines for gene therapy vectors. For his innovation and contribution to the field of animal cell culture technology, he received the inaugural 2019 ESACT Innovation Award. Prior to joining ProBioGen, he led a research group at Merck Research Laboratories, USA, focusing on the development of manufacturing systems for gutless adenoviruses and vectored vaccines. Volker holds a medical degree and received his doctorate in molecular biology from the Humboldt University of Berlin, Germany.